Iraq vs Namibia: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Iraq
82.0%
in 2025
Namibia
83.0%
in 2025
Iraq rank
106th
Namibia rank
104th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Iraq
- Namibia
How they compare
Namibia currently reports 83.0% against 82.0% in Iraq, a difference of 1.0%.
Across all 18 years both countries report, Namibia has been ahead every year.
Iraq ranks 106th and Namibia ranks 104th of 194 countries.
Namibia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Iraq | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 10.3% | 35.0% | 24.7% | Namibia |
| 2020s | 26.8% | 80.7% | 53.8% | Namibia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Iraq or Namibia?
- Namibia, at 83.0% against 82.0% in Iraq as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Iraq and Namibia?
- 1.0%, with Namibia ahead.
- How many years of comparable data are there for Iraq and Namibia?
- 18 years are reported by both, from 2008 to 2025.
- How do Iraq and Namibia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Iraq ranks 106th and Namibia ranks 104th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.